Mediclinic announced the appointment of Steve Weiner as an independent non-executive director and a member of the Audit and Risk and Clinical Performance and Sustainability committees with effect from 22 July 2020. Mr. Weiner is currently a non-executive director of Guys' and St Thomas' NHS Foundation Trust, where he chairs the Transformation and Major Programmes Committee. As announced on 24 July 2019, Dr. Edwin Hertzog is retiring as a non-executive director and Chair of Mediclinic at the conclusion of the Company's 2020 Annual General Meeting, being held and will be succeeded by Dame Inga Beale. Dr. Hertzog will receive no remuneration payment or payment for loss of office in connection with his retirement other than his usual director's fee for the month of July 2020 and any expenses incurred in attending Board meetings. The Board has agreed to certain changes to the membership of its committees reflecting Dr. Hertzog's retirement and Mr. Weiner's appointment. Mr. Weiner will be appointed as an additional member of the Audit and Risk Committee with effect from 22 July 2020. With effect from 22 July 2020, Dr. Hertzog will step down as Chair of the Nomination Committee and will be succeeded by Dame Inga Beale. With effect from 22 July 2020, Dr. Hertzog will step down as a member of the Clinical Performance and Sustainability Committee and Mr. Weiner will be appointed as a member of the Committee from that date.  Dr. Hertzog will step down as Chair and member of the Investment Committee with effect from 22 July 2020 and the Nomination Committee will consider the appointment of a new member to the Committee in due course. There are no changes to the composition of the Remuneration Committee.